The Food and Drug Administration has approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder. Venlafaxine hydrochloride extended ...

Pfizer is voluntarily recalling some lots of its antidepressant Effexor XR because a single capsule of a different medication was found in one bottle of the drug.The recall is for one lot of 30 ...

The FDA has approved new indications for extended-release venlafaxine HCl capsules (Effexor XR) and sodium oxybate oral solution (Xyrem), and a new dosing regimen for micronized fenofibrate ...

This is because of a pharmacist report that one bottle of Pfizer’s Effexor XR contained one capsule of Tikosyn (dofetilide) 0.25mg in addition to the Effexor XR capsules.

Pfizer announced a voluntary recall of venlafaxine HCl after a pharmacist reported that one bottle in the lot being recalled contained one capsule of dofetilide 0.25mg. The recall includes one lot ...

This voluntary recall includes one lot of 30-count Effexor XR 150mg capsules, one lot of 90-count Effexor XR 150mg capsules, and one lot of 90-count Greenstone LLC-branded Venlafaxine HCl 150mg ...

Venlafaxine tablets are indicated for the treatment of major depressive disorder only; the capsules and extended-release capsules are also indicated for the treatment of generalized anxiety ...

The 35 affected lots include Venlafaxine HCl ER 75mg Capsules and 150mg Capsules in 30-, 90-, and 1000-count bottles. Expiration dates range from September 2017 to December 2017.

Mylan Pharmaceuticals has entered into settlement and license agreements with Wyeth, now part of Pfizer, relating to venlafaxine HCl ER capsules in 37.5-, 75- and 150-mg strengths. The product is the ...

Reason for posting: A change in the prescribing information for venlafaxine has been issued by the US manufacturer, based on concerns that the antidepressant drug has been associated, in cases of ...